文献速递食管胃疾病与幽门螺杆菌

粪菌移植对复发性艰难梭菌感染患者胃肠道症状和总体健康的长期影响

The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection.
PubMed 文献 · Aliment Pharmacol Ther · 2017-12-11

该研究对84例复发性艰难梭菌感染患者进行平均3.8年随访,其中45例接受粪菌移植(FMT),39例接受抗生素治疗作为对照。FMT组肠道习惯改善更快、不规则排便及上消化道症状更少,心理健康改善报告更多,两组严重疾病发生率和体重增加无差异。

要点

  • FMT组与抗生素组严重疾病(炎症性肠病、癌症、自身免疫病、过敏、神经系统疾病)发生率无差异。
  • FMT组报告肠道习惯显著更快改善,不规则排便功能和上消化道症状更少。
  • FMT组报告心理健康改善的患者显著更多,两组对再次FMT的接受度均显著高于其他治疗选择。

核心结论

  • FMT是复发性艰难梭菌感染的持久、安全且可接受的长期治疗选择,并显示出优于抗菌治疗的潜在获益。

研究设计与样本

  • 回顾性问卷调查随访研究,共84例复发性艰难梭菌感染患者,其中45例接受FMT治疗,39例接受抗生素治疗作为对照,平均随访3.8年。

主要发现

  • FMT组与抗生素组严重疾病(炎症性肠病、癌症、自身免疫病、过敏、神经系统疾病)发生率无差异。
  • 两组体重增加无差异。
  • FMT组报告肠道习惯显著更快改善,不规则排便功能和上消化道症状均少于抗生素组。
  • FMT组报告心理健康改善的患者显著多于抗生素组。
  • 两组对潜在新发艰难梭菌感染接受FMT治疗的意愿均显著高于其他治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Faecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection. In short-term the treatment has been shown to be safe, however, there are no large, long-term follow-up studies looking into the potential adverse effects. AIM: To analyse the long-term effect of FMT treatment in patients with recurrent C. difficile infection and to compare the outcome to antibiotic treated patients. METHODS: Altogether 84 patients of which 45 received a FMT treatment and 39 served as controls receiving antibiotics for the infection were followed on average for 3.8 years. Their recovery and medical status was evaluated using a retrospective questionnaire, determining their quality of life, gastrointestinal symptoms and new diseases potentially related to the FMT. RESULTS: There was no difference in the incidence of severe diseases (inflammatory bowel disease, cancer, autoimmune disease, allergy, neurological diseases) between the patient groups. In addition, weight gain did not differ between treatment groups. The FMT treated patients reported that their bowel habits improved significantly faster, they had less irregular bowel function and less symptoms of upper GI-tract when compared to the patients treated with antibiotics. Significantly more patients in FMT-group reported that their mental health improved after the treatment. The willingness to receive FMT treatment for potential new C. difficile infection was significantly higher in both treatment groups compared to other treatment options. CONCLUSION: Our study highlights that FMT is a durable, safe and acceptable treatment option for patients with recurrent C. difficile infection also in long term, and it shows potential benefits over antimicrobial treatment.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Jalanka J, Hillamaa A, Satokari R, et al. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2017. PMID: 29226561. doi:10.1111/apt.14443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。